Article
Bristol-Myers Squibb to acquire Mirati in up to $5.8 billion deal
Rating:
0.0
Views:
73
Likes:
1
Library:
1
Bristol-Myers Squibb on Sunday said it will acquire cancer drugmaker Mirati Therapeutics for up to $5.8 billion, diversifying its oncology business and adding drugs it hopes can help offset expected lost revenue from patent expirations later this decade.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value